Application of critical path analysis in clinical trials

被引:4
|
作者
Kumar, Amal [1 ]
Chakraborty, Bhaswat S. [2 ]
机构
[1] Nirma Univ, Inst Pharm, Dept Pharmacol, Ahmadabad, Gujarat, India
[2] Cadila Pharmaceut Ltd, R&D Core Comm, Clin Res Org, Ahmadabad, Gujarat, India
关键词
Clinical trial operation; critical path analysis in clinical trial; decision model in clinical trial;
D O I
10.4103/2231-4040.173263
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Clinical research operates in a strictly regulated environment under various management models, but a distinct management model of clinical trial (CT) still needs exploration and research. Critical path analysis (CPA) is a management approach can be used for monitoring, analysis, and prediction of success of its time-bound operational activities. A model CT was compiled with 78 activities, which were further merged into 35 major activities. After performing dependence analysis, the list was finalized with 25 activities which were taken in activity predecessor to create a network diagram and perform CPA considering patients, conduct, and outcome. Activities were inclusive, described the trial entirely with accuracy, and were in chronological and logical sequences. This approach does not replace an understanding of or adherence to the requirements contained in all applicable regulations, guidelines or standard operating procedures governing clinical studies but ensures the proper use of operational and decisional approaches including optimal resource management. As the need to meet deadlines becomes more important and the need to produce good, stable project plans, CPA is very useful for determining activities that can lead to project delay. With this approach, project may be effectively monitored, and realistic schedules can be maintained.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 50 条
  • [1] CRITICAL ANALYSIS OF CLINICAL-TRIALS
    RAVIKIRAN, TN
    DATTA, H
    CHAUDHURY, RR
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 1980, 71 (MAR) : 460 - 464
  • [2] Guideline on critical analysis of urologist clinical trials
    Millan Rodriguez, Felix
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (06): : 654 - 666
  • [3] The Analysis of Critical Path which Affect the IT Application Maturity
    Peng, Jian Ping
    Zhou, Jing
    Ma, Delin
    [J]. NINTH WUHAN INTERNATIONAL CONFERENCE ON E-BUSINESS, VOLS I-III, 2010, : 2244 - 2249
  • [4] A critical analysis of neuro-oncology clinical trials
    Kim, Yeonju
    Armstrong, Terri S.
    Gilbert, Mark R.
    Celiku, Orieta
    [J]. NEURO-ONCOLOGY, 2023, 25 (09) : 1658 - 1671
  • [5] Critical path activities in clinical trial setup and conduct: How to avoid bottlenecks and accelerate clinical trials
    Bieske, Linn
    Zinner, Maximillian
    Dahlhausen, Florian
    Truebel, Hubert
    [J]. DRUG DISCOVERY TODAY, 2023, 28 (10)
  • [6] THE APPLICATION OF STRESS PATH AND CRITICAL STATE ANALYSIS TO SEDIMENT DEFORMATION
    JONES, ME
    ADDIS, MA
    [J]. JOURNAL OF STRUCTURAL GEOLOGY, 1986, 8 (05) : 575 - 580
  • [7] Deoxyribozymes: cleaving a path to clinical trials
    Dass, CR
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (08) : 395 - 397
  • [8] Clinical trials as a path toward equity
    Benson, Al B., III
    Carlos, Ruth C.
    [J]. CANCER, 2021, 127 (20) : 3717 - 3719
  • [9] CONTROVERSIES IN ANTIMICROBIAL THERAPY - CRITICAL ANALYSIS OF CLINICAL-TRIALS
    POLK, RE
    HEPLER, CD
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1986, 43 (03): : 630 - 640
  • [10] CRITICAL PATH ANALYSIS
    TAYLOR, DW
    [J]. METAL CONSTRUCTION AND BRITISH WELDING JOURNAL, 1970, 2 (11): : 505 - &